merck-co
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
IHSG
7.033,44
0.04%
-2,76
LQ45
1.010,67
0.16%
1,63
USD/IDR
15.243
0,58
EMAS
945.000
0,32%